OncoDaily Editor-in-Chief Gevorg Tamamyan Awarded 2026 Global Health Catalyst Distinguished Leader Award
FDA Grants Accelerated Approval to Camizestrant for ESR1-Mutated Advanced Breast Cancer
Highlights From LeukO 2026: Global Virtual Congress on Leukemias, Day 2
RATIONALE-306: Tislelizumab Plus Chemotherapy Shows Sustained 3-Year Survival Benefit in Advanced ESCC
Bob Li Highlights a Major Step Toward More Equitable Cancer Trials
Busy Philipps Reveals Oligodendroglioma Diagnosis: Symptoms, Treatment and Prognosis
The Invisible Patient: When Caring for Cancer Becomes Its Own Toxicity
10 Must-Read Posts In Radiotherapy This Week: August 24-30
